No double-digit losers this week, and both double-digit risers are related. OPTI:Optibiotix made a triumphant return to profit and rewarded all the 64p purchases by leaping 15% to 77p and is now £956 in profit. The worm has well and truly turned!
Share of the Week is an offspring of OPTI:Optibiotix, with SBTX:SkinBiotherapeutics climbing 24%. This is still 10% down on my purchase but on the way to recovery.
That's more like it!
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,570.14 | +£13.23 | |
| Portfolio sell value (bid price - commission) | £43,111.63 | (+1.3%) | +£2,128.18 |
| Potential profits | £4,495.71 | +£443.29 | |
| Yr 2 Dividends | £458.94 | +£93.90 | |
| Yr 2 Profit from sales | £2,401.06 | +£0 | |
| Yr 2 Average monthly cash profit | £298.71 | +£2.71 | |
| Yr 2 Avg annual % of current portfolio cost | 8.4% | ||
| Total Dividends | £1,126.87 | +£93.90 | |
| Total Profit from sales | £6.241.32 | +£0 | |
| Average monthly cash profit | £338.94 | +£0.74 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.6% |
Portfolio cost went up due to the open offer for RDT:Rosslyn Data. Although I don't hold out a huge amount of hope, the chance of increasing my holding by 10% for hardly any money and no commission had to be taken and brought the average price down from 17.52p to 15.85p. They are still 70% down though.
A staggering increase in value of £2,128 has brought the accounts back into the black. Hopefully this time it will last longer than a week! Of that, only £443 was increased profit. Most of it was reduction in loss for OPTI:Optibiotix, SBTX:SkinBiotherapeutics and KIBO:Kibo Mining.
There were lots of dividends this week, with £72.86 from GVC:GVC Holdings, £13.74 from TW.:Taylor Wimpey and £7.30 from BDEV:Barratt Developments, adding up to £93.90. This allowed the average monthly performance to creep up instead of the usual dip. I'm still below the target 10% though.
You might call this one volatile! All I can do is hope the green holds above the red for a while this time.
The SIPP looks like this after week 77
| Weekly Change | |||
| Portfolio cost | £17,468.71 | +£0 | |
| Portfolio sell value (bid price - commission) | £20,102.96 | (+15.1%) | +£1,061.39 |
| Potential profits | £3,359.62 | +£725.26 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £269.34 | -£11.23 | |
| Yr 2 Avg annual % of current portfolio cost | 18.5% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £240.09 | -£3.16 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 16.5% |
A superb £1,061 rise in value, £725 of which were increased profits and most of that was OPTI:Optibiotix, with a contribution from IQE:IQE which continued to climb, although much slower than recently. Performance took the usual slight dip due to no sales or dividends.
The gap isn't the widest it's been, but not far off.
The trading account looks like this after week 43
| Weekly Change | |||
| Portfolio cost | £986.03 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £873.89 | (-11.4%) | -£3.73 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.30 | +£0.06 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | -2.8% |
The increase in KIBO:Kibo Mining was offset by the drop in REDS:RedstoneConnect resulting in a drop of £3.73.
I think you can call this consistent - consistently rubbish!
No time to ponder what might happen next week as it's already next week now. A luke-warm start to the week today, but nothing to put the new super-buffer under threat.
No comments:
Post a Comment